Home / Share Price Target / Jagsnpharm
Jagsonpal Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts
Jagsonpal Pharmaceuticals Limited | |||
 | Symbol: JAGSNPHARM | ||
| Price: ₹413.79 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Jagsonpal Pharmaceuticals Brief Company Overview
- 1.1: Company Overview: Jagsonpal Pharmaceuticals Limited
- 1.1.1: Key Products and Services:
- 1.1.2: Reputation and Commitment:
- 1.2: Jagsonpal Pharmaceuticals Financial Performance
- 1.2.1: Is Jagsonpal Pharmaceuticals A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Jagsonpal Pharmaceuticals Share Price Target For 2024
- 2.1.1: Jagsonpal Pharmaceuticals Share Price Target Table For 2024
- 2.1.2: Summary: Jagsonpal Pharmaceuticals Share Price Prediction For 2024
- 2.2: Jagsonpal Pharmaceuticals Share Price Target For 2025
- 2.2.1: Jagsonpal Pharmaceuticals Share Price Target Table For 2025
- 2.2.2: Summary: Jagsonpal Pharmaceuticals Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Jagsonpal Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Jagsonpal Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Jagsonpal Pharmaceuticals Past Performance
Jagsonpal Pharmaceuticals Brief Company Overview
Company Overview: Jagsonpal Pharmaceuticals Limited
Established in 1978, Jagsonpal Pharmaceuticals Limited is a leading pharmaceutical company headquartered in New Delhi, India. The company specializes in manufacturing and trading pharmaceutical products and active pharmaceutical ingredients in various therapeutic areas.
Key Products and Services:
- Pharmaceutical formulations and over-the-counter drugs
- Women's health
- Pain and analgesics
- General medicine
Reputation and Commitment:
Jagsonpal Pharmaceuticals has earned a strong reputation in the industry for its commitment to quality and innovation. The company adheres to stringent manufacturing standards and is dedicated to providing affordable and accessible healthcare solutions to patients.
Advertisement
Jagsonpal Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,105.39 Crore | Market valuation of Jagsonpal Pharmaceuticals's shares. |
| Revenue (TTM) | 209.98 Crore | Total revenue generated by Jagsonpal Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | +20.31 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 14.91% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 9.67% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +2.1% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -28.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 4.77 | Company's total debt divided by total shareholder equity. |
| Total Debt | 8.94 Crore | Sum of Jagsonpal Pharmaceuticals's current & long-term financial obligations. |
| Total Cash | 147.93 Crore | Total amount of liquid funds available to Jagsonpal Pharmaceuticals. |
| Beta | 1.19 | Beta is greater than 1 indicating that the Jagsonpal Pharmaceuticals's price is more volatile than the market. |
Is Jagsonpal Pharmaceuticals A Good Buy For Long Term?
Jagsonpal Pharmaceuticals is a small-cap company with a strong track record of growth, having delivered a 1211.53% return over the past five years. While the recent quarter saw a decline in earnings (-28.7% YoY) and modest revenue growth (2.1% QoQ), the company boasts a healthy profit margin of 9.67%. Its robust cash balance of 147.93 Crore and low debt of 8.94 Crore provide a solid financial foundation. The stock's recent performance, with 26.89% returns over the past three months and 38.80% over the past six months, suggests positive market sentiment. Considering its long-term growth potential and healthy financials, Jagsonpal Pharmaceuticals could be a good buy for investors with a long-term horizon.
To predict the Jagsonpal Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Jagsonpal Pharmaceuticals Share Price Target For 2024
The line chart displays the monthly closing prices of Jagsonpal Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Jagsonpal Pharmaceuticals shares in 2024, see the table below.
Advertisement
Jagsonpal Pharmaceuticals Share Price Target Table For 2024
| Jagsonpal Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 436.00 (+5.36%) | Price Action: 04 Sep 2024 High |
| 2024 Target 2 | 429.90 (+3.89%) | Price Action: Nov 2023 High |
| 2024 Target 1 | 423.75 (+2.4%) | Fibonacci Extension Level 100% |
| Current Price | 413.79 | Jagsonpal Pharmaceuticals's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 410.14 (-0.89%) | Price Action: Sep 2024 Low |
| Stop Loss 2 | 405.00 (-2.13%) | Price Action: 07 Aug 2024 High |
| Stop Loss 3 | 398.95 (-3.59%) | Price Action: Jan 2023 High |
Summary: Jagsonpal Pharmaceuticals Share Price Prediction For 2024
In summary, Jagsonpal Pharmaceuticals has surged by ₹24.89, achieving a notable +6.40% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Jagsonpal Pharmaceuticals for 2024 predicts an additional rise of 2.4% to 5.36% by the end of 2024 with three potential targets T1: 423.75, T2: 429.90, T3: 436.00. Stop Loss at SL1: 410.14, SL2: 405.00, SL3: 398.95.
Jagsonpal Pharmaceuticals has a 52-week high of ₹475.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹273.60, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Jagsonpal Pharmaceuticals.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Jagsonpal Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Jagsonpal Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Jagsonpal Pharmaceuticals shares in 2025, see the table below.
Advertisement
Jagsonpal Pharmaceuticals Share Price Target Table For 2025
| Jagsonpal Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 587.01 (+41.86%) | Price Action: Chart |
| 2025 Target 2 | 576.06 (+39.21%) | Price Action: Chart |
| 2025 Target 1 | 570.36 (+37.83%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 413.79 | Jagsonpal Pharmaceuticals's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 378.00 (-8.65%) | Price Action: Oct 2023 Low |
| Stop Loss 2 | 374.00 (-9.62%) | Price Action: 14 Aug 2024 High |
| Stop Loss 3 | 370.00 (-10.59%) | Price Action: Nov 2022 High |
Summary: Jagsonpal Pharmaceuticals Share Price Prediction For 2025
In summary, Jagsonpal Pharmaceuticals has surged by ₹24.89, achieving a notable +6.40% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Jagsonpal Pharmaceuticals for 2025 predicts an additional rise of 37.83% to 41.86% by the end of 2025 with three potential targets T1: 570.36, T2: 576.06, T3: 587.01. Stop Loss at SL1: 378.00, SL2: 374.00, SL3: 370.00.
Jagsonpal Pharmaceuticals has a All-Time high of ₹514.84, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹273.60, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Jagsonpal Pharmaceuticals, we have created a specific page for that check here: Jagsonpal Pharmaceuticals Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Jagsonpal Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Jagsonpal Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 5.84% over the next 15 years.
For complete year by year Jagsonpal Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.
Jagsonpal Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Jagsonpal Pharmaceuticals Target | YoY Change % |
|---|---|---|
| 2024 | ₹413.79 | [Current Price] |
| 2024 | ₹386.64 | -6.57% |
| 2025 | ₹451.43 | 16.75% |
| 2026 | ₹396.95 | -12.07% |
| 2027 | ₹438.22 | 10.39% |
| 2028 | ₹484.55 | 10.57% |
| 2029 | ₹521.24 | 7.57% |
| 2030 | ₹598.35 | 14.79% |
| 2031 | ₹518.25 | -13.39% |
| 2032 | ₹564.41 | 8.9% |
| 2033 | ₹616.49 | 9.22% |
| 2034 | ₹655.84 | 6.38% |
| 2035 | ₹745.28 | 13.63% |
| 2036 | ₹639.54 | -14.19% |
| 2037 | ₹690.62 | 7.98% |
| 2038 | ₹748.43 | 8.37% |
| 2039 | ₹855.47 | 14.3% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Jagsonpal Pharmaceuticals Past Performance
- In 1993, Jagsonpal Pharmaceuticals opening price was ₹6.88
- As of Fri 06 Sep 2024 the price stands at ₹413.79.
- This represents a Compound Annual Growth Rate (CAGR) of 13.66%.
- In 31 years, an investment of 10,000 would have become ₹6.01 Lakh.
As we wrap up, we hope you like our study on Jagsonpal Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Jagsonpal Pharmaceuticals Share Price History
- Jagsonpal Pharmaceuticals Price Target Tomorrow
- Jagsonpal Pharmaceuticals Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
